Compare BCRX & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCRX | TSLX |
|---|---|---|
| Founded | 1986 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 1995 | 2011 |
| Metric | BCRX | TSLX |
|---|---|---|
| Price | $7.63 | $17.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $20.55 | $19.77 |
| AVG Volume (30 Days) | ★ 5.1M | 522.8K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 9.94% |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.71 | $4.55 |
| P/E Ratio | ★ N/A | $34.92 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.23 | $16.04 |
| 52 Week High | $11.22 | $22.84 |
| Indicator | BCRX | TSLX |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 54.36 |
| Support Level | $7.95 | $17.14 |
| Resistance Level | $9.22 | $17.94 |
| Average True Range (ATR) | 0.33 | 0.40 |
| MACD | 0.08 | 0.13 |
| Stochastic Oscillator | 53.73 | 66.38 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.